OR Foundation
  • About
    • Oral Reconstruction Foundation
      • Purpose and Mission
      • Foundation Board
      • Scientific Working Group
      • Education Working Group
      • History
      • Career
      • News
  • Granting
    • Requirements
    • Application
  • Publications
    • Grant Publications
    • Consensus Publications
  • Awards
    • Research Award
      • Awards 2018/2019
      • Award 2016/2017
      • Award 2014/2015
      • Award 2012/2013
      • Award 2010/2011
      • Award 2008/2009
    • Poster Competition
      • Competition 2018
      • Competition 2016
      • Competition 2014
      • Competition 2012
  • Education
    • International Symposia
    • Global Symposia
    • National Symposia
    • Curriculum
    • Education Courses
    • Webinars
  • Contact
Select Page

Synthetic bone substitute material comparable with xenogeneic material for bone tissue regeneration in oral cancer patients: First and preliminary histological, histomorphometrical and clinical results.


Ghanaati S, Barbeck M, Lorenz J, Stuebinger S, Seitz O, Landes C, Kovács AF, Kirkpatrick CJ, Sader RA

Annals of Maxillofacial surgery 2013;3(2):126-38 (Grant CF 3.003)

Abstract

Background:

The present study was first to evaluate the material-specific cellular tissue response of patients with head and neck cancer to a nanocrystalline hydroxyapatite bone substitute NanoBone (NB) in comparison with a deproteinized bovine bone matrix Bio-Oss (BO) after implantation into the sinus cavity.

Material and methods:

Eight patients with tumor resection for oral cancer and severely resorbed maxillary bone received materials according to a split mouth design for 6 months. Bone cores were harvested prior to implantation and analyzed histologically and histomorphometrically. Implant survival was followed-up to 2 years after placement.

Results:

Histologically, NB underwent a higher vascularization and induced significantly more tartrate-resistant acid phosphatase-positive (TRAP-positive) multinucleated giant cells when compared with BO, which induced mainly mononuclear cells. No significant difference was observed in the extent of new bone formation between both groups. The clinical follow-up showed undisturbed healing of all implants in the BO-group, whereas the loss of one implant was observed in the NB-group.

Conclusion:

Within its limits, the present study showed for the first time that both material classes evaluated, despite their induction of different cellular tissue reactions, may be useful as augmentation materials for dental and maxillofacial surgical applications, particularly in patients who previously had oral cancer.

SOURCE

Latest Research Award Winners

Dr. Yifan Zhang
Quantitative Clinical Adjustment Analysis of Posterior Single Implant Crown in a Chairside Digital Workflow: A Randomized Controlled Trial. Clin Oral Impl Res. 2019;30:1059-1066

Read more

Dr. Hyun-Chang Lim
Tissue integration of zirconia and titanium implants with and without buccal dehiscence defects — A histologic and radiographic preclinical study. Clin Oral Impl Res. 2019;30:660-9

Read more

Dr. Lorenzo Tavelli
Acellular dermal matrix and coronally advanced flap or tunnel technique in the treatment of multiple adjacent gingival recessions. A 12-year follow-up from a randomized clinical trial. J Clin Periodontol. 2019;46:937-48

Read more

Dr. Lukasz Witek
Repair of critical-sized long bone defects using dipyridamole-augmented 3D-printed bioactive ceramic scaffolds. J Orthop Res. 2019;37:2499-507

Read more

Oral Reconstruction Foundation


Margarethenstrasse 38 

4053 Basel
Switzerland

Phone: +41 61 565 41 51
Email: info@orfoundation.org

OR Foundation – U.S. Section

2300 Riverchase Center
Birmingham, AL 35244
USA
Phone: +1 205 986 7989
Email: info.us@orfoundation.org

Newsletter

  • Facebook
  • Twitter
  • RSS

© Oral Reconstruction Foundation 2023 | Imprint | Disclaimer | Privacy | Sitemap | Professional websites Basel